Cargando…
Systematic conversion to generic tacrolimus in stable kidney transplant recipients
BACKGROUND: Tacrolimus (Prograf(®)) is a key drug in the immunosuppressive treatment of renal transplant patients. Since the expiration of the patent for Prograf(®), generic preparations have been approved in Europe as bioequivalence has been shown in healthy volunteers. However, few studies have in...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970341/ https://www.ncbi.nlm.nih.gov/pubmed/24944783 http://dx.doi.org/10.1093/ckj/sfu015 |